Aurora Cannabis appoints Faris El Refaie as EVP, global commercial

• Aurora Cannabis named Faris El Refaie executive vice president, global commercial, effective Sept. 28, 2026.
• Role will lead global commercial acceleration for the medical cannabis business across Canada, Europe, Australia, New Zealand, other international markets.
• El Refaie previously held leadership roles at JAMP Pharma Group, GSK, AstraZeneca, spanning oncology, specialty care, vaccines, consumer healthcare.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202609090705PR_NEWS_USPR_____TO43089) on September 09, 2026, and is solely responsible for the information contained therein.